NRC adjusts exec compensation ahead of CEO transition; COO gets 100k share grant

NRC HEALTH

Trent Green to become CEO and director effective June 1, 2025, as previously announced.
COO Helen Hrdy received 100,000 restricted shares; cash bonus of 66 2/3% of share value; base salary stays $400k.
Hrdy forfeited unvested performance option for 100k shares; prior severance and 2024 LTIP terminated.
Same compensation changes apply to Chief Corporate Development Officer Andrew Monnich.
CEO Michael Hays' compensation unchanged.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Trent Green

Chief Executive Officer

NRC · NRC HEALTH

Effective: 2025-06-01
Filed: April 9, 2025, 7:59 PM ET

the board of directors of National Research Corporation, a Delaware corporation (the “Company”) appointed Trent Green as our Chief Executive Officer and to serve as a director, both effective June 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Trent Green was appointed as Chief Executive Officer at NRC HEALTH.

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

the board of directors of National Research Corporation, a Delaware corporation (the “Company”) appointed Trent Green as our Chief Executive Officer and to serve as a director, both effective June 1, 2025.

View on SEC.gov

NRC HEALTH filing history →

Source: SEC EDGAR

accession 0001437749-25-011529

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.